Jim Harper is the co-founder and chief operating officer of Sonde Health and has over 25 years of experience harnessing innovative technologies to provide solutions to important biological measurement problems. At Sonde he is building the platform to allow voice to be harnessed as a vital sign and meaningful predictor of health using devices we already own. 

Prior to Sonde he was at MIT Lincoln Laboratory for 15 years where he led development of new biotechnology and bioengineering capabilities and teams for a range of national security applications and government agencies. The projects he led rapidly transformed novel biotechnologies from laboratory proofs-of-concept to prototypes and deployed systems that have impacted national security and law-enforcement capabilities in biodefense, human DNA identification and characterization, and human health and performance monitoring. 

Dr. Harper received his BS in biochemistry from Furman University, his PhD in biochemistry from the MIT chemistry department, and was a postdoctoral research fellow at Harvard Medical School in the Center for Neurologic Diseases.